COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample

Evan M Bloch,Ruchika Goel,Xianming Zhu,Eshan U Patel,Shmuel Shoham,David J Sullivan,Kelly Gebo,Arturo Casadevall,Aaron A R Tobian

Clinical Infectious Diseases（2023）

引用 0|浏览5

暂无评分

摘要

Abstract COVID-19 convalescent plasma (CCP) use between October-December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations, and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要